Cargando…

What are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young West of Scotland patients prior to collagen cross linking?

Detalles Bibliográficos
Autores principales: Simpson, Alasdair, Brogan, Kerr, Ramaesh, Kanna, Lockington, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903035/
https://www.ncbi.nlm.nih.gov/pubmed/33627758
http://dx.doi.org/10.1038/s41433-021-01444-x
_version_ 1783654658679504896
author Simpson, Alasdair
Brogan, Kerr
Ramaesh, Kanna
Lockington, David
author_facet Simpson, Alasdair
Brogan, Kerr
Ramaesh, Kanna
Lockington, David
author_sort Simpson, Alasdair
collection PubMed
description
format Online
Article
Text
id pubmed-7903035
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79030352021-02-24 What are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young West of Scotland patients prior to collagen cross linking? Simpson, Alasdair Brogan, Kerr Ramaesh, Kanna Lockington, David Eye (Lond) Comment Nature Publishing Group UK 2021-02-24 2021-07 /pmc/articles/PMC7903035/ /pubmed/33627758 http://dx.doi.org/10.1038/s41433-021-01444-x Text en © The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2021
spellingShingle Comment
Simpson, Alasdair
Brogan, Kerr
Ramaesh, Kanna
Lockington, David
What are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young West of Scotland patients prior to collagen cross linking?
title What are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young West of Scotland patients prior to collagen cross linking?
title_full What are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young West of Scotland patients prior to collagen cross linking?
title_fullStr What are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young West of Scotland patients prior to collagen cross linking?
title_full_unstemmed What are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young West of Scotland patients prior to collagen cross linking?
title_short What are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young West of Scotland patients prior to collagen cross linking?
title_sort what are the costs, capacity, and clinical implications of ‘waiting for documented progression’ in young west of scotland patients prior to collagen cross linking?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903035/
https://www.ncbi.nlm.nih.gov/pubmed/33627758
http://dx.doi.org/10.1038/s41433-021-01444-x
work_keys_str_mv AT simpsonalasdair whatarethecostscapacityandclinicalimplicationsofwaitingfordocumentedprogressioninyoungwestofscotlandpatientspriortocollagencrosslinking
AT brogankerr whatarethecostscapacityandclinicalimplicationsofwaitingfordocumentedprogressioninyoungwestofscotlandpatientspriortocollagencrosslinking
AT ramaeshkanna whatarethecostscapacityandclinicalimplicationsofwaitingfordocumentedprogressioninyoungwestofscotlandpatientspriortocollagencrosslinking
AT lockingtondavid whatarethecostscapacityandclinicalimplicationsofwaitingfordocumentedprogressioninyoungwestofscotlandpatientspriortocollagencrosslinking